Search for Clinical Trial Results

Sponsored By

Neisseriaceae Infections - 25 Studies Found

Status Study
Terminated Study Name: Hormonal Contraception and Risk of Chlamydia and Gonorrhea
Condition:
  • Chlamydia Infection
  • Neisseriaceae Infection

Date: 2004-09-16
Interventions:
  • Drug: Depo Medroxyprogesterone acetate
  • Dru
Recruiting Study Name: South Australian Meningococcal B Vaccine Herd Immunity Study
Condition: Meningococcal Disease
Date: 2017-03-17
Interventions: Biological: Licensed 4CMenB vaccine Two doses (0.5 mL each) of Bexsero ® vaccine at least 1 month t
Recruiting Study Name: Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination
Condition: Infections, Meningococcal
Date: 2016-12-06
Interventions: Biological: Meningococcal (groups A, C, W and Y) oligosaccharide diphtheria CRM-197 conjugate Vaccine (Menveo)
Recruiting Study Name: Study to Assess the Immunological Long-term Persistence of Antibodies (Abs) 2 Years After GlaxoSmithKline (GSK) Meningococcal ABCWY Vaccination in the V102_15 (NCT02212457) and Response to a Booster in Adolescents
Condition: Infections, Meningococcal
Date: 2016-10-25
Interventions:
  • Biological: Meningococcal ABCWY Vaccine

Recruiting Study Name: PRIME Follow up - Quadri Meningo Vacinees
Condition: Meningococcal Disease
Date: 2016-06-15
Interventions: Other: venepuncture only single venepuncture
Active, not recruiting Study Name: Bexsero™and Routine Infant Vaccines: Effect of Coadministration on the Safety of Immunization
Condition: Meningococcal Infections
Date: 2016-03-14
Interventions:
  • Biological: 4CMenb Other Name:
Active, not recruiting Study Name: Safety and Immunogenicity of an Aluminium Hydroxide/LHD153R Adjuvanted Meningococcal C-CRM197 Conjugate Vaccine
Condition: Meningococcal Disease
Date: 2015-12-21
Interventions:
  • Biological: MenC-CRM conjugate vaccine with 12.5 ug LHD153R

Active, not recruiting Study Name: Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba)
Condition: Meningococcal Infections
Date: 2015-09-30
Interventions: Biological: Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals) All subjects will receive three doses of a T
Completed Study Name: A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years
Condition: MENINGOCOCCAL INFECTION
Date: 2015-08-20
Interventions:
  • Biological: Bivalent rLP2086 Vaccine

Completed Study Name: A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158)
Condition: Meningococcal Disease
Date: 2015-05-04
Interventions: Biological: MenABCWY+OMV vaccine Intramuscular injection of a single dose at Day 1 to subjects in the Me
Next >>>